简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-05-19 10:06 Oral‑B Announces The Big Rethink 2026, Launching One of Europe’s Largest Disability‑Focused Oral Health Studies
2026-05-18 14:16 Organon to Present New Research on Access and Value at ISPOR 2026
2026-05-15 11:17 BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma
2026-05-15 10:52 Amazfit Unveils the Cheetah 2 Ultra: The Performance Trail Running Watch Built to Master the Toughest Mountain Trails
2026-05-15 09:46 Medisca and dsm–firmenich Partner to Expand Access to Pharmaceutical-Grade Vitamin APIs for U.S. Compounding Market
2026-05-14 17:32 Aster Guardians Global Nursing Award Announces Top 10 Finalists for 2026
2026-05-14 14:54 Angelalign Technology Inc. (6699.HK) Applauds European Court Rejection of Patent Infringement Claim
2026-05-13 15:31 Takeda Announces FY2025 Full Year Results and FY2026 Outlook, Highlighted by Excellent Pipeline Progress and Solid FY2025 Results
2026-05-12 14:23 CORRECTING and REPLACING Samsung Epis Holdings Reports First Quarter 2026 Financial Results
2026-05-12 12:58 Fujirebio Announces CE Marking of the Fully Automated Lumipulse® G pTau 217 Plasma Assay
2026-05-12 10:13 HistoSonics Moves to Advance Additional Histotripsy Applications Announcing FDA Submission for Kidney Tumors
2026-05-11 09:37 WHOOP Expands Health Platform with On-Demand Clinician Access and New AI Features
2026-05-11 09:25 BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates
2026-05-09 16:44 Asset Value Investors (AVI) Urges Rohto Pharmaceutical to Focus on Core Businesses and Engage More Constructively with Shareholders
2026-05-09 11:17 Pioneering feat in regenerative medicine, the BEES-HAUS cell therapy: Paracrine effect and cell engraftment, together healing urethral stricture. Its simplified version, BHES-HAUS’ results to be presented in AUA 2026
2026-05-08 11:14 Department of Health - Abu Dhabi and ŌURA Partner to Advance Preventive Health in Abu Dhabi
2026-05-07 17:09 Chiesi Group to Acquire KalVista Pharmaceuticals, Expanding its Global Rare Disease Portfolio
2026-05-07 15:22 Takeda Announces Positive Topline Results from Pivotal Phase 2/3 Clinical Trial of TAK-881 in Primary Immunodeficiency Disease (PID)
2026-05-07 11:31 TIME Names Xenco Medical one of the TIME100 Most Influential Companies in the World and the Winner of the 2026 TIME100 Impact Award in Health
2026-05-07 11:06 MRM Health’s Lead Candidate MH002 Granted Fast Track Designation by U.S. FDA for the Treatment of Mild-to-Moderate Ulcerative Colitis

Business Wire Weibo

Press Releases

Latest Releases